Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Indoco Remedies Ltd

NSE: INDOCO · BSE: 532612 · Pharmaceuticals & Biotechnology · 33 announcements

Share price
₹246.10
Market cap
₹2,272 Cr
Revenue (annual)
₹1,845 Cr
Net profit (annual)
₹-95.14 Cr
P/E (TTM)
403.5×Sector 47.4×
Promoter holding
58.86%+0.00% QoQ
FII holding
1.27%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:18 IST NSE
Regulatory Approval

Indoco Remedies Regulatory Approval

Indoco Remedies received EU GMP certification from German Health Authority for its Baddi plant. This approval validates compliance with European standards for international markets.

11:02 IST BSE
Regulatory Approval

Indoco Remedies Regulatory Approval

Indoco Remedies received EU GMP certification from the Malta Medicines Authority for its Baddi facility. This approval validates compliance with global quality standards for international markets.

18:34 IST BSE
Regulatory Approval

Indoco Remedies Regulatory Approval

Indoco Remedies Limited announced that the U.S. FDA successfully completed a Pre-Approval Inspection at its testing facility in Chhatrapati Sambaji Nagar (Aurangabad). The inspection, conducted from April 08-10, 2026, concluded with zero Form 483 observations, confirming compliance with regulatory standards.